Think the Forbes article stated the intent was to kill off all T-cells so Juno treatment would take hold with less toxicity. Oops. I think this is a buying opportunity.
I dont think anyone pays attention but i'll take positive news and earnings!
Sentiment: Strong Buy
I'm thinking UTHR, KITE, MYL, SGEN. They need to buy something, the stock would pop on the news.
These hit pieces are always released during the company quiet period before earnings so management can't respond.